Company intelligence / Profile preview

BrachyDOSE

Ownership: Private
Development stage: Other

Overview

BrachyDOSE is currently in the clinical testing phase and pursuing CE/MDR certification. The company has collaborated with the National Cancer Centre of Vilnius University Hospital Santaros Clinics and the Oncology Hospital of the Lithuanian University of Health Sciences for testing purposes.

Therapeutic areas: Oncology
Modalities: Device
Industry: Digital Health Medical Devices

Partnerships

National Cancer Centre of Vilnius University Hospital Santaros ClinicsOncology Hospital of the Lithuanian University of Health Sciences

Beyond the preview

Go deeper on BrachyDOSE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BrachyDOSE.

Explore the full profile